These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23301386)

  • 1. Is the immunohistochemical expression of proliferation (Ki-67) and apoptosis (Bcl-2) markers and cyclooxigenase-2 (COX-2) related to carcinogenesis in postmenopausal endometrial polyps?
    Antunes A; Andrade LA; Pinto GA; Leão R; Pinto-Neto AM; Costa-Paiva L
    Anal Quant Cytopathol Histpathol; 2012 Oct; 34(5):264-72. PubMed ID: 23301386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Bcl-2 and Ki-67 in tamoxifen-associated endometrial polyps: comparison with postmenopausal polyps.
    Altaner S; Gucer F; Tokatli F; Guresci S; Ozdemir C; Puyan FO; Kutlu K
    Onkologie; 2006 Sep; 29(8-9):376-80. PubMed ID: 16974115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
    Giordano G; Gnetti L; Merisio C; Melpignano M
    Maturitas; 2007 Feb; 56(2):190-7. PubMed ID: 16963204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone receptor expressions and proliferation markers in postmenopausal endometrial polyps.
    Inceboz US; Nese N; Uyar Y; Ozcakir HT; Kurtul O; Baytur YB; Kandiloglu AR; Caglar H; Fraser IS
    Gynecol Obstet Invest; 2006; 61(1):24-8. PubMed ID: 16141722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociated expression of Bcl-2 and Ki-67 in endometrial lesions: diagnostic and histogenetic implications.
    Risberg B; Karlsson K; Abeler V; Lagrelius A; Davidson B; Karlsson MG
    Int J Gynecol Pathol; 2002 Apr; 21(2):155-60. PubMed ID: 11917225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: An approach using multiparameter flow cytometry.
    Morsi HM; Leers MP; Radespiel-Tröger M; Björklund V; Kabarity HE; Nap M; Jäger W
    Gynecol Oncol; 2000 Apr; 77(1):11-7. PubMed ID: 10739685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of hormone receptors, Bcl‑2, Cox‑2 and Ki67 in benign endometrial polyps and their association with obesity.
    Pinheiro A; Antunes A; Andrade L; De Brot L; Pinto-Neto AM; Costa-Paiva L
    Mol Med Rep; 2014 Jun; 9(6):2335-41. PubMed ID: 24718434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How often are endometrial polyps malignant in asymptomatic postmenopausal women? A multicenter study.
    Ferrazzi E; Zupi E; Leone FP; Savelli L; Omodei U; Moscarini M; Barbieri M; Cammareri G; Capobianco G; Cicinelli E; Coccia ME; Donarini G; Fiore S; Litta P; Sideri M; Solima E; Spazzini D; Testa AC; Vignali M
    Am J Obstet Gynecol; 2009 Mar; 200(3):235.e1-6. PubMed ID: 19027096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of Ki-67, p53, Bcl-2, and Cox-2 biomarkers for low-grade endometrial cancer and disordered proliferative/benign hyperplastic endometrium by imprint cytology.
    Apostolou G; Apostolou N; Biteli M; Kavantzas N; Patsouris E; Athanassiadou P
    Diagn Cytopathol; 2014 Feb; 42(2):134-42. PubMed ID: 23729350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of malignancy in endometrial polyps in premenopausal and postmenopausal women according to clinicopathologic characteristics.
    Costa-Paiva L; Godoy CE; Antunes A; Caseiro JD; Arthuso M; Pinto-Neto AM
    Menopause; 2011 Dec; 18(12):1278-82. PubMed ID: 21926931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial polyps in pre- and postmenopausal women: factors associated with malignancy.
    Antunes A; Costa-Paiva L; Arthuso M; Costa JV; Pinto-Neto AM
    Maturitas; 2007 Aug; 57(4):415-21. PubMed ID: 17587515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of an immunocytochemical double-labeling staining can display the distribution of Bcl-2/Ki-67 cells in endometrial adenocarcinomas as well as in normal endometrium.
    Mourtzikou A; Kosmas K; Marouga A; Stamouli M; Pouliakis A; Karakitsos P
    Clin Lab; 2012; 58(1-2):133-44. PubMed ID: 22372356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of p53, Ki-67, and CD31 proteins in endometrial polyps of postmenopausal women treated with tamoxifen.
    Miranda SP; Traiman P; Cândido EB; Lages EL; Freitas GF; Lamaita RM; Vidigal PV; da Silva Filho AL
    Int J Gynecol Cancer; 2010 Dec; 20(9):1525-30. PubMed ID: 21119367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opportunities and risk factors for premalignant and malignant transformation of endometrial polyps: management strategies.
    Wang JH; Zhao J; Lin J
    J Minim Invasive Gynecol; 2010; 17(1):53-8. PubMed ID: 20129333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and adjacent endometrium in postmenopausal women.
    Sant'Ana de Almeida EC; Nogueira AA; Candido dos Reis FJ; Zambelli Ramalho LN; Zucoloto S
    Maturitas; 2004 Nov; 49(3):229-33. PubMed ID: 15488351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
    Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
    In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ki-67, Bcl-2 and p53 expression in endometrial polyps and in the normal endometrium during the menstrual cycle.
    Maia H; Maltez A; Studart E; Athayde C; Coutinho EM
    BJOG; 2004 Nov; 111(11):1242-7. PubMed ID: 15521869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does tamoxifen therapy affect the hormone receptor expression and cell proliferation indices of endometrial polyps? An immunohistochemical comparison of endometrial polyps from postmenopausal women exposed and not exposed to tamoxifen.
    McGurgan P; Taylor LJ; Duffy SR; O'Donovan PJ
    Maturitas; 2006 Jun; 54(3):252-9. PubMed ID: 16413707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferation in Postmenopausal Endometrial Polyps-A Potential for Malignant Transformation.
    Adomaitienė L; Nadišauskienė R; Nickkho-Amiry M; Čižauskas A; Palubinskienė J; Holland C; Seif MW
    Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31466367
    [No Abstract]   [Full Text] [Related]  

  • 20. An immunohistochemical comparison of endometrial polyps from postmenopausal women exposed and not exposed to HRT.
    McGurgan P; Taylor LJ; Duffy SR; O'Donovan PJ
    Maturitas; 2006 Mar; 53(4):454-61. PubMed ID: 16169691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.